Skip to main content
logo
Abbott Laboratories (ABT)
NYSE: ABT · Real-Time Price · USD
99.60
+1.11 (1.13%)
At close: Oct 9, 2026, 4:00 PM EDT
99.70
+0.10 (0.10%)
After-hours: Oct 9, 2026, 7:59 PM EDT

Abbott Laboratories Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Revenue
12,59311,16411,45911,36911,14210,35810,97410,63510,3779,96410,24110,1439,9789,74710,09110,41011,25711,89511,46810,928
Revenue Growth
13.02%7.78%4.42%6.90%7.37%3.95%7.16%4.85%4.00%2.23%1.49%-2.56%-11.36%-18.06%-12.01%-4.74%10.11%13.76%7.17%23.44%
Gross Profit
7,2686,2746,5466,2946,2885,8906,0945,9375,7745,5015,7415,5385,4955,4165,5575,7816,3246,9087,1596,505
Operating Income
1,8521,5042,4772,2052,1981,8402,1761,9941,8081,5182,1451,7691,6771,6291,7481,8722,4823,0112,9542,614
Net Income
9281,0771,7521,6441,7791,3259,2271,6461,3021,2251,5881,4311,3641,3181,0291,4292,0092,4381,9812,092
Earnings Per Share
0.530.611.000.941.010.765.260.940.740.700.910.820.780.750.590.811.141.371.111.17
EPS Growth
-47.52%-19.74%-80.95%0%36.49%8.57%479.45%14.63%-5.06%-6.67%55.01%1.23%-31.63%-45.23%-47.23%-30.77%72.73%36.94%-7.54%69.56%

Revenue by Segment
Chart
Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Established Pharmaceutical Products
1,4991,4261,3821,5111,3831,2601,2681,4061,2941,2261,2221,3681,2871,1891,2161,3261,2231,1471,2031,265
Nutritionals
2,1442,0171,9402,1532,2122,1462,1292,0662,1502,0682,0382,0732,0761,9671,8171,7951,9531,8942,0422,108
Diagnostics
3,0922,1802,4572,2532,1732,0542,5202,4122,1952,2142,5342,4492,3172,6883,2773,6414,3225,2574,4713,912
Medical Devices
5,8535,5395,6755,4485,3694,8955,0524,7474,7344,4534,4434,2494,2953,9003,7783,6453,7573,5943,7493,632
Other Segment
525453544344333323311
Revenue (Total)
12,59311,16411,45911,36911,14210,35810,97410,63510,3779,96410,24110,1439,9789,74710,09110,41011,25711,89511,46810,928

Cash & Debt
Chart
Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Cash & Investments
5,6037,2958,9397,7337,2826,8447,9687,7887,2196,6517,2797,0478,1559,53210,1709,9079,2908,15810,2499,692
Total Debt
32,72034,13614,13612,97513,47013,29015,32615,04614,84514,70515,96815,69916,98817,02617,96616,58016,84117,12419,25118,397
Net Cash (Debt)
-27,117-26,841-5,197-5,242-6,188-6,446-7,358-7,258-7,626-8,054-8,689-8,652-8,833-7,494-7,796-6,673-7,551-8,966-9,002-8,705
Net Cash Growth
--------------------
Net Cash Per Share
-15.56-15.36-2.97-3.00-3.53-3.69-4.21-4.15-4.35-4.60-4.97-4.95-5.05-4.28-4.44-3.78-4.28-5.05-5.05-4.87

Cash Flow & CapEx
Chart
Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Operating Cash Flow
2,4881,3153,3152,7872,0471,4172,8682,7051,9601,0253,0381,8771,2031,1432,3262,7802,4102,0653,0672,701
Capital Expenditures
-497-399-689-496-502-484-720-556-533-398-755-560-507-380-610-467-379-321-614-461
Free Cash Flow
1,9919162,6262,2911,5459332,1482,1491,4276272,2831,3176967631,7162,3132,0311,7442,4532,240
Free Cash Flow Growth
28.87%-1.82%22.25%6.61%8.27%48.80%-5.91%63.17%105.03%-17.82%33.04%-43.06%-65.73%-56.25%-30.04%3.26%18.43%-22.14%-21.35%42.68%

Margins
Chart
Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Gross Margin
57.72%56.20%57.13%55.36%56.44%56.86%55.53%55.83%55.64%55.21%56.06%54.60%55.07%55.57%55.07%55.53%56.18%58.07%62.43%59.53%
Operating Margin
14.71%13.47%21.62%19.39%19.73%17.76%19.83%18.75%17.42%15.24%20.95%17.44%16.81%16.71%17.32%17.98%22.05%25.31%25.76%23.92%
Pretax Margin
12.10%12.98%20.58%19.17%19.30%17.17%18.50%18.24%15.49%14.41%17.53%16.47%16.40%16.03%13.08%16.89%20.89%24.18%20.29%22.81%
Profit Margin
7.37%9.65%15.29%14.46%15.97%12.79%84.08%15.48%12.55%12.29%15.51%14.11%13.67%13.52%10.20%13.73%17.85%20.50%17.27%19.14%
FCF Margin
15.81%8.21%22.92%20.15%13.87%9.01%19.57%20.21%13.75%6.29%22.29%12.98%6.98%7.83%17.00%22.22%18.04%14.66%21.39%20.50%

Dividends
Chart
Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Dividend Per Share
0.6300.6300.6300.5900.5900.5900.5900.5500.5500.5500.5500.5100.5100.5100.5100.4700.4700.4700.4700.450
Dividend Per Share Growth
6.78%6.78%6.78%7.27%7.27%7.27%7.27%7.84%7.84%7.84%7.84%8.51%8.51%8.51%8.51%4.44%4.44%4.44%4.44%25.00%
Dividend Yield
2.75%2.41%1.95%1.80%1.75%1.77%2.05%2.01%2.18%1.97%2.00%2.24%1.96%2.08%1.89%2.11%1.86%1.70%1.42%1.68%

Valuation
Chart
Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
PE Ratio
29.2628.6033.5216.6816.9317.0414.6434.4332.5935.1733.5232.6936.8830.4227.7221.5722.3327.1334.2829.04
Forward PE
16.2118.7822.6324.7725.7725.7622.3923.1621.8024.6024.2221.5824.6423.0226.6423.7525.4324.4630.0528.18
P/FCF Ratio
20.2024.2429.4633.7034.9334.5630.8930.5831.9740.0637.7737.4234.5425.7924.5319.8422.4725.6027.9122.49
PS Ratio
3.393.964.925.325.495.434.684.814.444.894.764.214.714.244.393.764.184.695.604.95